eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Phase III randomized trial of adjuvant chemotherapy with or without bevacizumab for patients with completely resected stage IB (> 4cm)-IIIA non-small lung cancer (NSCLC)

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
  3. Additional Topic(s)
    Combined antineoplastic chemotherapy
  4. Resource Description
    Giving chemotherapy together with bevacizumab after surgery may kill any tumor cells that remain after surgery. This randomized phase III trial is studying chemotherapy and bevacizumab to see how well they work compared to chemotherapy alone in treating patients with stage IB, stage II, or stage IIIA non-small cell lung cancer that was removed by surgery.
  5. Contact
    Berenberg, Jeffrey
  6. PI
    Berenberg, Jeffrey
  7. Topic
    non-small cell lung carcinoma
  8. Study Population
    Males and females at least 18 years old who have undergone surgery to completely remove the tumor within the past 6-12 weeks and who are 5 years past hormone or radiation therapy for cancer.
  9. Website(s)
  10. Website(s)
  11. Funded by
    Cancer Trials Support Unit
  12. Phase
    Phase 3 clinical trial
  13. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016